Loading...
InMed Pharmaceuticals Inc.
INM•NASDAQ
HealthcareBiotechnology
$2.67
$-0.28(-9.66%)
InMed Pharmaceuticals Inc. (INM) Quarterly Earnings Reports & Financial Results
Analyze InMed Pharmaceuticals Inc.’s revenue, EPS, and earnings surprises to assess performance and investor sentiment over recent quarters.
Total Reports
0
Avg EPS
N/A
Avg Revenue
N/A
Beats Estimates
0 out of 0
Max EPS
N/A
Min EPS
N/A
Earnings Visualization
Visual comparison of InMed Pharmaceuticals Inc.’s actual vs. estimated earnings across recent quarters.
No data available
InMed Pharmaceuticals Inc. (INM) Quarterly Earnings Details
Detailed breakdown of InMed Pharmaceuticals Inc.’s earnings per share (EPS), revenue estimates vs. actuals, and earnings surprises by quarter.